23andMe IPF Research Study
NCT05028894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 690
Last updated 2024-12-09
Summary
The long term goal of this study is to increase genetic understanding of IPF to enable the development of an effective drug for IPF that can improve the lives of those living with the condition.
Conditions
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
23andMe, Inc.
lead INDUSTRY
Principal Investigators
-
Suyash Shringarpure · 23andMe, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-05
- Primary Completion
- 2023-05-05
- Completion
- 2023-05-05
Countries
- United States
Study Locations
More Related Trials
-
Role of Genetic Factors in the Development of Lung Disease
NCT00001532 ·Status: RECRUITING
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
NCT00608764 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Development of Airway Absorption Sampling Methods
NCT04494334 ·Status: WITHDRAWN
-
The Genetics of Pulmonary Fibrosis
NCT03478553 ·Status: RECRUITING
-
Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
NCT05022784 ·Status: COMPLETED
-
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT01071707 ·Status: COMPLETED
-
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005317 ·Status: COMPLETED
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
NCT00018408 ·Status: COMPLETED
-
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329 ·Status: RECRUITING
-
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
NCT02187393 ·Status: WITHDRAWN
-
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
NCT02055222 ·Status: COMPLETED
-
Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
NCT06702228 ·Status: RECRUITING
-
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
NCT00725309 ·Status: COMPLETED
-
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
NCT03958071 ·Status: COMPLETED
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Genetics of Airway Responsiveness and Lung Function
NCT00005537 ·Status: COMPLETED
-
Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935 ·Status: ACTIVE_NOT_RECRUITING
-
Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
NCT01695408 ·Status: COMPLETED
-
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
NCT02151435 ·Status: COMPLETED
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED